# FDA Inspection 1003235 - Vitalant - December 15, 2016

Source: https://www.keypedia.com/records/fda_inspections/vitalant/6ddcb354-ddea-48bb-afb9-bcb0317d908f
Source feed: FDA_Inspections

> FDA Inspection 1003235 for Vitalant on December 15, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003235
- Company Name: Vitalant
- Inspection Date: 2016-12-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1101508 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/vitalant/14a6d4d5-6c97-42ae-84bb-ac2d660741d4)
- [FDA Inspection 923767 - 2015-03-30](https://www.keypedia.com/records/fda_inspections/vitalant/75238fe1-edd2-45a0-8df6-eaa29ca29d5d)
- [FDA Inspection 814381 - 2013-01-16](https://www.keypedia.com/records/fda_inspections/vitalant/e7d4d95e-7d79-4140-b44b-4ae0e3af453b)
- [FDA Inspection 701076 - 2010-12-06](https://www.keypedia.com/records/fda_inspections/vitalant/613d8796-d150-40d0-8449-e6b4bb600558)

Company: https://www.keypedia.com/companies/vitalant/7f7e7100-2b96-4fef-91cf-375827fdffa7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d